Ligand Pharmaceuticals Inc (LGND)

Income Before Tax

$64.30M

Quarterly · Period ending: · USD

LGND logo

LGND Income Before Tax

Latest reported$64.30M
LGND Quarterly Pre-Tax Income (-$6.90M → $64.30M)
High-resolution chart · PNG

LGND income before tax history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Ligand Pharmaceuticals Inc Income Before Tax — Quarterly (USD)
Period endingIncome Before Tax (USD)
64,304,000
-24,259,000
56,780,000
141,137,000
11,223,000
-50,180,000
-39,200,000
-6,339,000
-65,390,000
113,447,000
17,097,000
-12,144,000
3,171,000
55,536,000
55,930,000
12,354,000
8,661,000
-9,144,000
-7,026,000
15,259,000
33,301,000
5,764,000
3,370,000
-11,612,000
28,119,000
-30,415,000
-8,175,000
-19,871,000
-18,028,000
842,713,000
-56,789,000
79,226,000
95,579,000
55,312,000
30,665,000
12,071,000
8,300,000
6,193,000
7,230,000
804,000
-9,644,000
9,571,000
5,826,000
7,284,000
22,292,000
-74,000
7,012,000
901,000
1,241,000
2,150,000
2,008,000
2,025,000
3,804,000
1,370,000
950,000
-52,000
-3,728,000
-522,000
5,997,000
-3,884,000
-773,000
-4,292,000
-1,587,000
-11,436,000
335,000
-2,715,000
1,034,000
1,055,000
-4,476,000
-7,482,000
-73,964,000
-6,134,000
-5,919,000
-11,498,000
-8,240,000
-7,222,000
-11,911,000
-26,083,000
4,506,000
-16,969,000
-15,940,000
-142,212,000
69,963,000
-6,264,000
-8,907,000
-18,452,000
-94,410,000
-4,125,000
-14,216,000
-13,139,000
-37,462,000
-11,087,000
-11,997,000
-20,320,000
-32,596,000
-7,047,000
-9,804,000
-4,614,000
-10,161,000
-4,755,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.